The injection of MC38-TREM2+DAP12 cells resulted in an approximately five-fold reduction in tumor volume compared with the injection of MC38-vector cells, implying that TREM2 overexpression dramatically suppressed tumor incidence (Figure 5B,C). The gene discussed is TREM2; the disease is neoplasm.